UBS ASSET MANAGEMENT AMERICAS LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$902,020
+123.7%
15,536
+53.0%
0.00%
Q2 2023$403,2780.0%10,1530.0%0.00%
Q1 2023$403,278
+96.9%
10,153
+99.4%
0.00%
Q4 2022$204,851
-99.9%
5,092
-21.5%
0.00%
Q3 2022$208,428,000
-13.5%
6,485
-20.2%
0.00%
Q2 2022$241,009,000
+12.7%
8,123
+6.8%
0.00%
Q1 2022$213,889,000
-39.0%
7,6090.0%0.00%
Q4 2021$350,623,000
+40.4%
7,6090.0%0.00%
Q3 2021$249,729,000
-6.4%
7,6090.0%0.00%
Q2 2021$266,696,000
+8.8%
7,609
+12.2%
0.00%
Q1 2021$245,101,000
+4.7%
6,782
+18.0%
0.00%
Q1 2020$234,092,000
-36.9%
5,746
-4.4%
0.00%
Q4 2019$370,821,000
-27.3%
6,013
-14.1%
0.00%
Q3 2019$510,015,000
+13.9%
6,998
+28.5%
0.00%
Q2 2019$447,661,000
+32.5%
5,446
+13.7%
0.00%
Q1 2019$337,887,000
+791.4%
4,790
+468.9%
0.00%
Q4 2018$37,907,000
+12049.7%
842
-82.1%
0.00%
Q3 2016$312,000
+26.8%
4,700
+6.8%
0.00%
Q2 2016$246,000
+13.4%
4,400
-8.3%
0.00%
Q4 2015$217,000
-20.5%
4,800
+9.1%
0.00%
Q2 2015$273,0004,4000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders